Literature DB >> 19151598

Molecular basis of Parkinson's disease.

Yan Xiang Yang1, Nicholas W Wood, David S Latchman.   

Abstract

Parkinson's disease is the second most common neurodegenerative disorder and remains incurable. Considerable progress has been made in understanding the molecular mechanisms of this disease, in particular, a distinct set of genes have emerged, whose dysfunctional regulation is strongly associated with the condition. These genes include alpha-synuclein, parkin, PTEN induced Putative Kinase 1 (PINK1), DJ-1, Leucine Rich Repeat Kinase 2 (LRRK2) and ATP13A2. Here we discuss what has been learnt in the study of these genes and how these genes may contribute to the pathogenesis of Parkinson's disease through different molecular pathways, and consider how these pathways might converge to lead to the onset of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19151598     DOI: 10.1097/WNR.0b013e32831c50df

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  25 in total

1.  Engineered disulfide bonds restore chaperone-like function of DJ-1 mutants linked to familial Parkinson's disease.

Authors:  Todd Logan; Lindsay Clark; Soumya S Ray
Journal:  Biochemistry       Date:  2010-07-13       Impact factor: 3.162

Review 2.  Missing pieces in the Parkinson's disease puzzle.

Authors:  Jose A Obeso; Maria C Rodriguez-Oroz; Christopher G Goetz; Concepcion Marin; Jeffrey H Kordower; Manuel Rodriguez; Etienne C Hirsch; Matthew Farrer; Anthony H V Schapira; Glenda Halliday
Journal:  Nat Med       Date:  2010-05-23       Impact factor: 53.440

Review 3.  Integration of clearance mechanisms: the proteasome and autophagy.

Authors:  Esther Wong; Ana Maria Cuervo
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-11-10       Impact factor: 10.005

Review 4.  Tyrosine hydroxylase and regulation of dopamine synthesis.

Authors:  S Colette Daubner; Tiffany Le; Shanzhi Wang
Journal:  Arch Biochem Biophys       Date:  2010-12-19       Impact factor: 4.013

Review 5.  Chaperone-mediated autophagy dysfunction in the pathogenesis of neurodegeneration.

Authors:  Hiroshi Koga; Ana Maria Cuervo
Journal:  Neurobiol Dis       Date:  2010-07-17       Impact factor: 5.996

6.  Silencing of SIAH1 in SH-SY5Y affects α-synuclein degradation pathway.

Authors:  Jing Xu; Xin-Zhi Zhang; Yong-Jin Zhang; Xiu-Ming Li; Zeng-Lin Cai; Xiao-Min Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 7.  Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.

Authors:  Khosro Jamebozorgi; Eskandar Taghizadeh; Daryoush Rostami; Hosein Pormasoumi; George E Barreto; Seyed Mohammad Gheibi Hayat; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-11-05       Impact factor: 5.590

Review 8.  Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models.

Authors:  Ruben K Dagda; Jianhui Zhu; Charleen T Chu
Journal:  Mitochondrion       Date:  2009-06-27       Impact factor: 4.160

9.  DJ-1 deficient mice demonstrate similar vulnerability to pathogenic Ala53Thr human alpha-syn toxicity.

Authors:  Chenere P Ramsey; Elpida Tsika; Harry Ischiropoulos; Benoit I Giasson
Journal:  Hum Mol Genet       Date:  2010-01-20       Impact factor: 6.150

10.  Manganese-induced toxicity in normal and human B lymphocyte cell lines containing a homozygous mutation in parkin.

Authors:  Jerome A Roth; Balakrishnan Ganapathy; Andrew J Ghio
Journal:  Toxicol In Vitro       Date:  2012-07-26       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.